Contact Us: 01282 426380
KM Financial Solutions | UPDATE 2-Alnylam’s gene-silencing efforts get $2 bln Blackstone backing
71022
post-template-default,single,single-post,postid-71022,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 2-Alnylam’s gene-silencing efforts get $2 bln Blackstone backing

12 Apr UPDATE 2-Alnylam’s gene-silencing efforts get $2 bln Blackstone backing

Posted at 15:31h in News by
0 Likes
Blackstone Group Inc said on
Monday it would invest $2 billion in Alnylam Pharmaceuticals Inc
through an equity-and-debt deal, giving the drugmaker a
financial boost without tapping into currently volatile stock
markets for funds.

No Comments

Sorry, the comment form is closed at this time.